Chemomab Therapeutics News

Chemomab Therapeutics | 424B5: Prospectus

Nov 16 05:10

Chemomab Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Sep 13 04:59

Chemomab Therapeutics | 424B3: Prospectus

Sep 9 18:20

Chemomab Therapeutics | EFFECT: Others

Sep 9 18:06

Chemomab Therapeutics | EFFECT: Others

Nov 6, 2023 13:15

Chemomab Therapeutics | 424B5: Prospectus

Apr 26, 2022 04:19

Chemomab Therapeutics | EFFECT: Others

May 18, 2021 12:15

Chemomab Therapeutics | 424B3: Prospectus

Apr 29, 2021 18:10

Chemomab Therapeutics | EFFECT: Others

Apr 29, 2021 12:15

Chemomab Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Mar 10, 2021 07:32

Chemomab Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Mar 10, 2021 02:00

Chemomab Therapeutics | 424B3: Prospectus

Feb 13, 2021 01:05

Chemomab Therapeutics | EFFECT: Others

Feb 11, 2021 13:15

Chemomab Therapeutics | S-4/A: Registration of securities issued in business combination transactions (Amendment)

Feb 11, 2021 02:19

Chemomab Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Feb 9, 2021 03:15

Chemomab Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Feb 2, 2021 22:22

Chemomab Therapeutics | S-4: Registration of securities issued in business combination transactions

Jan 13, 2021 22:30

Chemomab Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Jan 11, 2021 23:50

Chemomab Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Jan 5, 2021 22:36

Chemomab Therapeutics | 424B4: Prospectus

Feb 13, 2019 21:20